Beckman Coulter to be bought out by Danaher
10 February 2011 00:00 in Scientific Company News
Beckman Coulter has signed a definitive merger agreement that will see it become a subsidiary of the diversified manufacturing and technology company Danaher.
The transaction is valued at $6.8 billion (4.24 billion pounds) and will result in Beckman Coulter becoming part of the life sciences and diagnostics division of Danaher, alongside firms such as Leica and Radiometer.
Bob Hurley, Beckman Coulter's president and chief executive officer, said Danaher's offer has been accepted following a thorough and competitive process and will serve to strengthen the organisation's long-term prospects.
"We believe this transaction maximises Beckman Coulter shareholder value while strengthening the company's position as a leader in biomedical testing, to the benefit of our customers and their healthcare patients around the world," he added.
The takeover is expected to be completed during the first half of the current calendar year.
According to the firm's most recent financial report last October, Beckman Coulter saw year-on-year growth in 2010, driven in part by the acquisition of Olympus Diagnostics.
Other news stories from 10/02/2011
Read more in the Zenopa News Archive
How this news is generated
Story collated for Zenopa by the Adfero News Agency